• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background Intravenous beta-blockers are commonly used to manage patients with acute
atrial fibrillation (AF) and atrial flutter (AFl), but the choice of specific agent is often not …

Heart failure with preserved ejection fraction (HFpEF) and AF are two common
cardiovascular conditions that are inextricably linked to each other's development and …

Patients with heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF)
have increased mortality and increased risk of stroke. Due to the heterogeneous nature of …

Worldwide, atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults,
associated with substantial morbidity and mortality [1]. Demographic factors (age, male sex …

Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice
projected to affect 12.1 million individuals by the year 2030. Patients who are diagnosed …

Heart failure (HF) is a common cause of mortality and morbidity, especially in older adults;
however, clinical guidelines for its management in the elderly are based at best on moderate …

Aquesta tesi descriu: 1. Incidència i mortalitat en pacients amb insuficiència cardíaca, així
com la utilització de recursos en atenció primària després del diagnòstic. Període entre …

Аннотация Цель. Оценить исходы 10-летнего наблюдения пациентов с фибрилляцией
предсердий (ФП) после госпитализации в различные отделения многопрофильного …

Background Intravenous beta-blockers are commonly used to manage patients with acute
atrial fibrillation (AF) and atrial flutter (AFl), but the choice of specific agent is often not …